NCT02790944View on ClinicalTrials.gov

Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 4, 2016

Primary Completion Date

August 15, 2020

Study Completion Date

August 15, 2020

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
GENETIC

Multi-gene Next Generation Sequencing Panel

Participants will have genetic testing

Trial Locations (3)

15232

University of Pittsburgh Medical Center, Pittsburgh

85258

HonorHealth Research Institute, Scottsdale

02215-5400

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

Ambry Genetics
All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

HonorHealth Research Institute

OTHER

lead

Ambry Genetics

INDUSTRY